Source: Agilent Technologies
Get a clearer view of monoclonal antibody quality by combining two powerful analytical techniques. This piece shows how SEC quantifies monomers and aggregates under native conditions, while CE-SDS reveals detailed low-molecular-weight fragments that SEC can miss. Used together, they deliver a stronger, more confident assessment of NISTmAb impurities and overall antibody integrity.
Read the full application note to see side-by-side results and learn how to apply both methods for better impurity characterization.
Offered Free by: Bioprocess Online
See All Resources from: Bioprocess Online
